INOZYME PHARMA, INC. Form D Notices of Exempt Offering of Securities
Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.
- 2020-06-08: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2018-11-09; Total offering amount $67,399,993.
- 2020-03-27: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2018-11-09; Total offering amount $33,699,996.
- 2019-03-29: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2018-11-09; Total offering amount $33,699,996.
- 2018-11-21: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2018-11-09; Total offering amount $10,699,996.
| Filed | Federal exemption | Types of securities offered | Date of first sale | Total offering amount | Total amount sold | Total remaining to be sold | Investors who have already invested |
|---|---|---|---|---|---|---|---|
| 2020-06-08 D/A | Rule 506(b) | Equity | 2018-11-09 | $67,399,993 | $67,399,993 | $0 | 12 |
| 2020-03-27 D/A | Rule 506(b) | Equity | 2018-11-09 | $33,699,996 | $33,699,996 | $0 | 11 |
| 2019-03-29 D/A | Rule 506(b) | Equity | 2018-11-09 | $33,699,996 | $33,699,996 | $0 | 11 |
| 2018-11-21 | Rule 506(b) | Equity | 2018-11-09 | $10,699,996 | $10,699,996 | $0 | 5 |
| 2018-11-21 D/A | Rule 506(b) | Equity | 2017-01-17 | $48,850,000 | $48,850,000 | $0 | 14 |
| 2017-01-12 D/A | Rule 506(b) | Equity | Yet to occur | Indefinite | $0 | Indefinite | 0 |
| 2017-01-05 | Rule 506(b) | Equity | Yet to occur | Indefinite | $0 | Indefinite | 0 |